FHL1 and hypertrophic cardiomyopathy: Mutations in distal exons that encode the third and fourth LIM domains, as well as frameshift mutations leading to reduced FHL1 expression, are associated with non-reducing body disorders such as hypertrophic cardiomyopathy and EDMD.